Market cap of Ensysce Biosciences Inc. [ENSC] reaches 84.06M – now what?

Ensysce Biosciences Inc. [NASDAQ: ENSC] jumped around 0.27 points on Friday, while shares priced at $3.42 at the close of the session, up 8.57%. The company report on November 16, 2022 that ENSC: Getting Closer to Commercialization.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.


By Brad Sorensen, CFA.

Ensysce Biosciences Inc. stock is now -96.36% down from its year-to-date (YTD) trading value. ENSC Stock saw the intraday high of $4.71 and lowest of $3.17 per share. The company’s 52-week high price is 140.00, which means current price is +80.00% above from all time high which was touched on 01/06/22.

Compared to the average trading volume of 613.21K shares, ENSC reached a trading volume of 4609661 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Ensysce Biosciences Inc. [ENSC]?

The Average True Range (ATR) for Ensysce Biosciences Inc. is set at 0.70 The Price to Book ratio for the last quarter was 11.40, with the Price to Cash per share for the same quarter was set at 0.00.

How has ENSC stock performed recently?

Ensysce Biosciences Inc. [ENSC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.65. With this latest performance, ENSC shares dropped by -13.77% in over the last four-week period, additionally sinking by -66.81% over the last 6 months – not to mention a drop of -89.94% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENSC stock in for the last two-week period is set at 53.93, with the RSI for the last a single of trading hit 62.13, and the three-weeks RSI is set at 48.53 for Ensysce Biosciences Inc. [ENSC]. The present Moving Average for the last 50 days of trading for this stock 3.75, while it was recorded at 2.74 for the last single week of trading, and 12.49 for the last 200 days.

Ensysce Biosciences Inc. [ENSC]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Ensysce Biosciences Inc. [ENSC] shares currently have an operating margin of -562.71 and a Gross Margin at +100.00. Ensysce Biosciences Inc.’s Net Margin is presently recorded at -823.62.

Ensysce Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.70.

Insider trade positions for Ensysce Biosciences Inc. [ENSC]

There are presently around $1 million, or 14.50% of ENSC stock, in the hands of institutional investors. The top three institutional holders of ENSC stocks are: HG VORA CAPITAL MANAGEMENT, LLC with ownership of 123,125, which is approximately 0% of the company’s market cap and around 33.90% of the total institutional ownership; VANGUARD GROUP INC, holding 15,791 shares of the stock with an approximate value of $54000.0 in ENSC stocks shares; and BLACKROCK INC., currently with $40000.0 in ENSC stock with ownership of nearly 0% of the company’s market capitalization.

Positions in Ensysce Biosciences Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 11 institutional holders increased their position in Ensysce Biosciences Inc. [NASDAQ:ENSC] by around 30,984 shares. Additionally, 7 investors decreased positions by around 33,185 shares, while 7 investors held positions by with 129,218 shares. The mentioned changes placed institutional holdings at 193,387 shares, according to the latest SEC report filing. ENSC stock had 5 new institutional investments in for a total of 18,281 shares, while 7 institutional investors sold positions of 33,185 shares during the same period.


Please enter your comment!
Please enter your name here